Since TIMP1 is significantly related to the OS of CRC patients, and the high expression of TIMP1 is correlated to a poor prognosis, we next looked for drugs/small molecules that can reverse the expression of TIMP1, which might improve the prognosis of CRC patients. The gene discussed is TIMP1; the disease is colorectal carcinoma.